MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/iju.70326

Медицинская библиотека · International journal of urology : official journal of the Japanese Urological Association · 2025

Impact of Age on Treatment Patterns and Outcomes in Patients With Non-Metastatic Castration-Resistant Prostate Cancer.

Hagimoto Hiroki, Sakamoto Shinichi, Sato Kodai, Nakamura Kazuyoshi, Kito Hiroki, Fukasawa Satoshi, Hino Daichi, Shiraishi Yusuke, Hashimoto Kohei, Matsushita Yuto, Narita Shintaro, Miki Jun, Kato Takuma, Matsumoto Ryuji, Saito Toshihiro, Tomida Ryotaro, Kimura Takahiro, Kitamura Hiroshi, Ichikawa Tomohiko, Matsui Yoshiyuki, Japan Urological Oncology Group (JUOG)

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

OBJECTIVES

To evaluate the impact of age on treatment patterns and outcomes in patients with non-metastatic castration-resistant prostate cancer (nmCRPC).

METHODS

We conducted a retrospective multicenter analysis of 428 patients with nmCRPC from 25 tertiary centers (2002-2022). Patients were divided into two age groups: < 80 and ≥ 80 years. The outcomes included cancer-specific survival (CSS), overall survival (OS), and progression-free survival (PFS).

RESULTS

Among 428 patients (median follow-up, 32.5 months), performance status (PS) 0 was more frequent in < 80 vs. ≥ 80 years (78% vs. 58%, p < 0.001). Use of first-line androgen receptor signaling inhibitors (ARSIs) was similar (58% vs. 59%, p = 0.83) among all, whereas any-line docetaxel use was less common in patients aged ≥ 80 years (33% vs. 9% for < 80 vs. ≥ 80, p < 0.001). Five-year CSS was 76.5% vs. 63.7% (p = 0.002) and five-year OS 73.8% vs. 59.9% (p = 0.006) for < 80 vs. ≥ 80 years, respectively. Time-to-treatment failure was shorter in patients aged ≥ 80 years (p = 0.04).

CONCLUSION

Maintaining PS and managing ARSI-related adverse events are essential in older patients with nmCRPC and may preserve their eligibility for chemotherapy and improve their prognosis.

Для цитирования: Hagimoto Hiroki, Sakamoto Shinichi, Sato Kodai, Nakamura Kazuyoshi, Kito Hiroki, Fukasawa Satoshi, Hino Daichi, Shiraishi Yusuke, Hashimoto Kohei, Matsushita Yuto, Narita Shintaro, Miki Jun, Kato Takuma, Matsumoto Ryuji, Saito Toshihiro, Tomida Ryotaro, Kimura Takahiro, Kitamura Hiroshi, Ichikawa Tomohiko, Matsui Yoshiyuki, Japan Urological Oncology Group (JUOG). Impact of Age on Treatment Patterns and Outcomes in Patients With Non-Metastatic Castration-Resistant Prostate Cancer.. International journal of urology : official journal of the Japanese Urological Association. 2025. DOI: 10.1111/iju.70326.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.